Cost-Benefit Analysis of Genetic Testing as a Prenatal Diagnostic Tool for Thalassemia: A Single-Center Study From Central Thailand
These findings are particularly valuable for policymakers, as they provide robust evidence supporting potential revisions to the reimbursement structure within Thailand's Universal Health Coverage benefit package, facilitating better management of thalassemia and improving prenatal care.
Authors
- Sitaporn Youngkong (ORCID: https://orcid.org/0000-0002-2448-3954)
- Sermsiri Sangroongruangsri (ORCID: https://orcid.org/0000-0002-5222-8694)
- Usa Chaikledkaew (ORCID: https://orcid.org/0000-0001-9457-9823)
- Wanvisa Udomsinprasert (ORCID: https://orcid.org/0000-0002-1132-7442)
- Jiraphun Jittikoon (ORCID: https://orcid.org/0000-0003-4987-3497)
- Pattarawalai Talungchit (ORCID: https://orcid.org/0000-0002-3668-8754)
- Surakameth Mahasirimongkol (ORCID: https://orcid.org/0000-0002-7555-1056)
- Kwandao Malasai
Institutions
- Mahasarakham University (TH)
- Ministry of Public Health (TH)
- Siriraj Hospital (TH)
- Mahidol University (TH)
Publication Details
- Journal
- ClinicoEconomics and Outcomes Research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/ceor.s500802
- Citations
- 3
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 4.88
Funders
- Mahidol University
- Mahasarakham University
- Faculty of Medicine Siriraj Hospital, Mahidol University